Correlation Between Ortin Laboratories and Beta Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ortin Laboratories and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ortin Laboratories and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ortin Laboratories Limited and Beta Drugs, you can compare the effects of market volatilities on Ortin Laboratories and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ortin Laboratories with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ortin Laboratories and Beta Drugs.

Diversification Opportunities for Ortin Laboratories and Beta Drugs

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Ortin and Beta is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Ortin Laboratories Limited and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Ortin Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ortin Laboratories Limited are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Ortin Laboratories i.e., Ortin Laboratories and Beta Drugs go up and down completely randomly.

Pair Corralation between Ortin Laboratories and Beta Drugs

Assuming the 90 days trading horizon Ortin Laboratories Limited is expected to under-perform the Beta Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Ortin Laboratories Limited is 1.03 times less risky than Beta Drugs. The stock trades about -0.01 of its potential returns per unit of risk. The Beta Drugs is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  175,770  in Beta Drugs on September 2, 2024 and sell it today you would earn a total of  41,415  from holding Beta Drugs or generate 23.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy71.43%
ValuesDaily Returns

Ortin Laboratories Limited  vs.  Beta Drugs

 Performance 
       Timeline  
Ortin Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ortin Laboratories Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Ortin Laboratories is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Beta Drugs 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Ortin Laboratories and Beta Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ortin Laboratories and Beta Drugs

The main advantage of trading using opposite Ortin Laboratories and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ortin Laboratories position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.
The idea behind Ortin Laboratories Limited and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk